MyoKardia (MYOK) reported earnings on Thur 2 Nov 2017 (b/o)

** charts after earnings **

MyoKardia reports EPS in-line, misses on revs 

• Reports Q3 (Sep) loss of $0.42 per share, in-linewith the Capital IQ Consensus of ($0.42); revenues rose 58.6% year/year to $5.63 mln vs the $6.1 mln Capital IQ Consensus.
• Cash and cash equivalents as of September 30, 2017 were $227.2 million, compared to $135.8 million as of December 31, 2016.